Increased demands from communications and remote sensing systems on a limited radio frequency (RF) spectrum motivate design of dual-function radar communications (DFRC) systems. Simultaneously ...

FDA blocks new use for AstraZeneca's Ultomiris AstraZeneca has been successful at rolling out its long-acting complement C5 inhibitor Ultomiris in the uses approved for its predecessor Soliris ...